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The inducible lL-3 and GM-CSF genes can only be effi-
ciently expressed in T cells once they have been through
a previous cycle of activation and undergone a process
termed blast cell transformation [1]. An initial stimulus is
required to bring naive T cells out of the resting state
and into the cell cycle. This process is triggered by T cell
receptor (TCR) stimulation, takes about 24 hours, and is
associated with extensive nuclear remodeling. Once
primed by a cycle of activation, T blast cells can maintain
their ability to express lL-3 and GM-CSF for many cell
divisions without the continual need for additional sti-
muli. In contrast, the lL-3 and GM-CSF genes cannot be
induced in naive T cells that have never received a TCR
stimulus. We show that this pattern of regulation of the
IL-3/GM-CSF locus is controlled at two distinct levels:
(1) During blast cell transformation, the IL-3/GM-CSF
locus acquires an extensive array of DNase I Hypersensi-
tive Sites (DHSs) which are then maintained indefinitely
for many cell cycles [1,2]. These primed DHSs are marked
by me2K4 histone H3, and they also persist in non-dividing
memory T cells in the peripheral blood [1]. These DHSs
are absent in the thymus, spleen T cells, and naive T cells
in the blood. These DHSs do not function as classical
enhancers, and we propose that they serve to maintain an
active chromatin structure in previously activated T cells.
(2) The expression of the lL-3 and GM-CSF genes is in
each case dependent on the activation of inducible
upstream enhancers. The lL-3 and GM-CSF enhancers
appear as inducible DHSs T blast cells within 20 min of
stimulation, and only acquire the me2K4H3 modification
after stimulation. These enhancers are dependant on the
TCR inducible factors NFAT and AP-1. However,
although AP-1 and NFAT family mRNAs are efficiently
expressed in both naive T cells and in T blast cells, the
enhancers only respond to induction of these factors in
T blast cells. The inducible DHSs remain completely
undetectable in naive T cells even after 4 hours of stimu-
lation with direct activators of TCR signaling pathways
(PMA and Calcium ionophore).
We propose that T blast cells and memory T cells have
developed a strategy of maintaining a discrete class of
DHS as epigenetic memory modules that support an
accessible chromatin environment and thereby prime
inducible genes for efficient re-activation when memory
cells re-encounter Ag stimuli. In the absence of the prim-
ing elements, the lL-3/GM-CSF locus appears to remain
inaccessible to transcription factors that are otherwise very
efficient at recruiting the chromatin remodelers that create
DHSs within the inducible enhancers.
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